Skip to Content

WATSON 405 (Lisinopril 2.5 mg)

Pill with imprint WATSON 405 is , Round and has been identified as Lisinopril 2.5 mg. It is supplied by Watson Pharmaceuticals.

Lisinopril is used in the treatment of diabetic kidney disease; heart attack; high blood pressure; heart failure and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Lisinopril 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 405

Lisinopril

Imprint
WATSON 405
Strength
2.5 mg
Size
6.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Angiotensin converting enzyme inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals
National Drug Code (NDC)
00591-0405
Inactive Ingredients
silicon dioxide, calcium phosphate dihydrate dibasic, magnesium stearate, mannitol, corn starch

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.